Answers are grounded in this paper and cite their sources.
The landscape of acute COVID-19 therapeutics has dramatically evolved since the onset of the pandemic. The treatment of acute COVID-19 in children and adolescents requires knowledge of risk factors and clinical features to appropriately select antiviral and immunomodulatory therapies. This review article provides updated guidance for emergency physicians in the treatment of acute COVID-19 in children and adolescents.
No takes yet. Share an insight, caveat, or question.
Daniels et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: